Last reviewed · How we verify

NCT07331090

Evaluation of Removable Appliances and Clear Aligners in Early Orthodontic Treatments During the Mixed Dentition Period

Completed Last updated 12 January 2026
What this trial tests

trial in Malocclusion in 24 participants. Completed in 15 May 2025.

Timeline
15 May 2024
Primary endpoint
20 November 2024
15 May 2025

Quick facts

Lead sponsorNeslihan Atmaca
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date15 May 2024
Primary completion20 November 2024
Estimated completion15 May 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Neslihan Atmaca

Who can join

Adults 6 to 12, any sex, with Malocclusion or Crossbite. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare two different orthodontic treatment modalities-clear aligners and removable appliances-in children aged 6 to 12 years during the mixed dentition period. The primary focus of the research is to evaluate treatment-related changes in oral hygiene status, oral health-related quality of life, pain and anxiety levels, and speech function. By assessing multiple dimensions associated with early orthodontic intervention, the study seeks to provide a comprehensive understanding of how different appliance types influence clinical, functional, and psychosocial outcomes in pediatric patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Malocclusion

Currently open trials in the same condition.

Other Neslihan Atmaca trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07331090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing